BRIEF-EMA Starts Safety Review Of Janus Kinase Inhibitors For Inflammatory Disorders

Reuters | Updated: 11-02-2022 17:20 IST | Created: 11-02-2022 17:11 IST

BRIEF-EMA Starts Safety Review Of Janus Kinase Inhibitors For Inflammatory Disorders — Representative Image

EMA:

* EMA: EMA STARTS SAFETY REVIEW OF JANUS KINASE INHIBITORS FOR INFLAMMATORY DISORDERS: 11/02/2022 Source text for Eikon:

TRENDING

1

WRAPUP 2-Iran threatens to strike other nations' energy fields if US launches fresh attacks

WRAPUP 2-Iran threatens to strike other nations' energy fields if US launche...

Iran

2

EXCLUSIVE-Japan to announce Tokyo, Washington took joint action on yen, sources say

EXCLUSIVE-Japan to announce Tokyo, Washington took joint action on yen, sour...

Japan

3

WRAPUP 3-Trump says he will hold off on fresh Iran attack in hope of quick deal

WRAPUP 3-Trump says he will hold off on fresh Iran attack in hope of quick d...

United States

4

Athletics-Kerr caps 'great two weeks' with Commonwealth Games gold on home soil

Athletics-Kerr caps 'great two weeks' with Commonwealth Games gold on home s...

United Kingdom

PERSPECTIVES AND INSIGHTS

Can Digital Finance Keep Factories Running Through the Next Global Shock?

Future Pandemics Need Research Networks Ready Before Crisis Strikes: Here's Why

The Governance–Reality Gap Derailing Africa’s Digital Transformation

Liberia's Recovery Is Real, but Financing the Next Growth Phase Remains the Biggest Challenge

DevShots

Latest News

Connect us on

Facebook Twitter LinkedIn Quora Youtube

Google News RSS

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

Name

Email

Message

By submitting, you agree that we may use your email address to respond.

Web Analytics Made Easy - Statcounter